The Overlooked Autoantibody Repertoire: Exploring the Biomarker Potential of Downregulated Autoantibodies in NSCLC

Documenti analoghi

• Persist or resist: Immune checkpoint inhibitors in EGFR‐mutated NSCLC
  di: Pengcheng Zhu, et al.
  Pubblicazione: (2024)
• The Pro‐Apoptotic Effect of Glucose Restriction in NSCLC via AMPK‐Regulated Circadian Clock Gene Bmal1
  di: Tao Wei, et al.
  Pubblicazione: (2025)
• Peripheral Blood T‐Cell Receptor Repertoire Diversity as a Potential Biomarker in the Diagnosis and Treatment Evaluation of Colorectal and Lung Cancers: A Prospective Observational Study
  di: Jilong Ma, et al.
  Pubblicazione: (2025)
• Spatial Heterogeneity of PD‐L1 Expression as a Biomarker for Third‐Generation EGFR‐TKI Response in Advanced EGFR‐Mutant NSCLC
  di: Yidan Zhang, et al.
  Pubblicazione: (2025)
• KAT2A Deficiency Suppresses Lung Cancer Progression by Downregulating MYC Through Decreasing MYC Succinylation
  di: Junping Li, et al.
  Pubblicazione: (2025)